Product Name:2-(4-iodopentyl)isoindole-1,3-dione

IUPAC Name:2-(4-iodopentyl)-2,3-dihydro-1H-isoindole-1,3-dione

CAS:63460-47-9
Molecular Formula:C13H14INO2
Purity:95%+
Catalog Number:CM341453
Molecular Weight:343.16

Packing Unit Available Stock Price($) Quantity

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:63460-47-9
Molecular Formula:C13H14INO2
Melting Point:-
Smiles Code:O=C1N(CCCC(I)C)C(C2=C1C=CC=C2)=O
Density:
Catalog Number:CM341453
Molecular Weight:343.16
Boiling Point:
MDL No:
Storage:

Column Infos

Tafenoquine
60 Degrees Pharmaceuticals recently announced it has entered into an agreement with Tufts Medical Center in Boston to conduct the world’s first clinical trial evaluating the efficacy and safety of tafenoquine in treating human babesiosis patients. The FDA has granted its investigational tafenoquine candidate orphan drug designation for the treatment of patients with acute babesiosis.
Tafenoquine was approved for malaria prophylaxis in 2018 in the United States as ARAKODA and in Australia as KODATEF. It is an antimalarial indicated for the prophylaxis of malaria in patients aged 18 years of age and older.